CAOHF yields 2000000.00% · JNJ yields 2.14%● Live data
📍 CAOHF pulled ahead of the other in Year 1
Combined, CAOHF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CAOHF + JNJ for your $10,000?
FDG Electric Vehicles Limited, an investment holding company, researches, designs, develops, manufactures, and sells electric vehicles in the People's Republic of China, the United States, Hong Kong, and internationally. It operates through Vehicle Design and Electric Vehicle Production, Battery Materials Production, and Direct Investments segments. The company also researches, develops, manufactures, and sells cathode materials for nickel-cobalt-manganese lithium-ion batteries and lithium ferrous phosphate batteries. In addition, it sells and distributes electric vehicles and battery products; human resources, administrative management, and consultancy services; and loan financing and securities trading services. Further, the company is involved in the asset investment activities; and purchase and sale of battery raw materials. The company was formerly known as Sinopoly Battery Limited and changed its name to FDG Electric Vehicles Limited in May 2014. FDG Electric Vehicles Limited is headquartered in Wanchai, Hong Kong.
Full CAOHF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.